Your browser doesn't support javascript.
loading
Stem Cell-Derived Cardiomyocyte-Like Cells in Myocardial Regeneration.
Cheng, Pauline; Rashad, Ahmad; Gangrade, Ankit; Barros, Natan Roberto de; Khademhosseini, Ali; Tam, Jonathan; Varadarajan, Padmini; Agrawal, Devendra K; Thankam, Finosh G.
Afiliación
  • Cheng P; Department of Translational Research, Western University of Health Sciences, Pomona, California, USA.
  • Rashad A; Terasaki Institute for Biomedical Innovation (TIBI), Los Angeles, California, USA.
  • Gangrade A; Terasaki Institute for Biomedical Innovation (TIBI), Los Angeles, California, USA.
  • Barros NR; Terasaki Institute for Biomedical Innovation (TIBI), Los Angeles, California, USA.
  • Khademhosseini A; Terasaki Institute for Biomedical Innovation (TIBI), Los Angeles, California, USA.
  • Tam J; Department of Translational Research, Western University of Health Sciences, Pomona, California, USA.
  • Varadarajan P; University of California Riverside School of Medicine, Riverside, California, USA.
  • Agrawal DK; Department of Translational Research, Western University of Health Sciences, Pomona, California, USA.
  • Thankam FG; Department of Translational Research, Western University of Health Sciences, Pomona, California, USA.
Tissue Eng Part B Rev ; 30(1): 1-14, 2024 02.
Article en En | MEDLINE | ID: mdl-37294202
Myocardial infarction results in the significant loss of cardiomyocytes (CMs) due to the ischemic injury following coronary occlusion leading to impaired contractility, fibrosis, and ultimately heart failure. Stem cell therapy emerged as a promising regenerative strategy to replenish the otherwise terminally differentiated CM to restore cardiac function. Multiple strategies have been applied to successfully differentiate diverse stem cell populations into CM-like phenotypes characterized by the expression status of signature biomarkers and observable spontaneous contractions. This article discusses the current understanding and applications of various stem cell phenotypes to drive the differentiation machinery toward CM-like lineage. Impact Statement Ischemic heart disease (IHD) extensively affects a large proportion of the population worldwide. Unfortunately, current treatments for IHD are insufficient to restore cardiac effectiveness and functionality. A growing field in regenerative cardiology explores the potential for stem cell therapy following cardiovascular ischemic episodes. The thorough understanding regarding the potential and shortcomings of translational approaches to drive versatile stem cells to cardiomyocyte lineage paves the way for multiple opportunities for next-generation cardiac management.
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Miocitos Cardíacos / Infarto del Miocardio Límite: Humans Idioma: En Revista: Tissue Eng Part B Rev Asunto de la revista: BIOTECNOLOGIA / HISTOLOGIA Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Miocitos Cardíacos / Infarto del Miocardio Límite: Humans Idioma: En Revista: Tissue Eng Part B Rev Asunto de la revista: BIOTECNOLOGIA / HISTOLOGIA Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos